Pharmaceutical

The Assistance Fund Opens New Program for Immunoglobulin G4-Related Disease

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Immunoglobulin G4-Related Disease ORLANDO, FLORIDA / ACCESS…

2 months ago

SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer

Executive leadership expansion in long-term care pharmacy technology reflects the growing demand driven by America's aging population and rising senior…

2 months ago

Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer

Company advances digital technology initiatives with approval to publish applications on the Google Play Store. MESA, ARIZONA / ACCESS Newswire…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

Stemtech Corporation – Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell…

2 months ago

Stemtech Corporation – Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of…

2 months ago